Rothschild Predicts Apple Stock Will Rise 31% Thanks to the Foldable iPhone
An analyst at the company raised the company's stock rating to "buy"

The market is currently undervaluing the anticipated first foldable iPhone, and investors should take advantage of this. Photo: Wongsakorn 2468/Shutterstock
The market is currently undervaluing the anticipated first foldable iPhone, and investors should take advantage of this, according to Rothschild & Co. analyst Timm Schulze-Melander, as quoted by CNBC. Rothschild has upgraded Apple’s stock rating from “neutral” to “buy,” and its new price target of $400 implies 31% upside potential from the latest closing price.
Why an Analyst Believes in Apple
A potential foldable iPhone will enter the “ultra-premium segment of the smartphone market,” which “aligns perfectly with Apple’s brand positioning, suggesting that a well-designed product is likely to be a market success,” according to Schulze-Melander.
"The strength of Apple's product lineup and its entry into the foldable device market appear to be underestimated by the market. We expect Apple’s entry into the ultra-premium segment of foldable phones to increase the average selling price of the iPhone by 11% by June 2027,” the analyst noted.
According to forecasts by Rothschild & Co., sales of the foldable iPhone Ultra model will total 14 million units in fiscal year 2027. Of these, by conservative estimates, only 4 million will “cannibalize” sales of traditional iPhones—out of a total volume of 257 million units: this represents a limited impact of 2%, the strategist notes.
Apple has not yet officially confirmed plans to release a foldable phone. However, numerous media reports suggest that the company is preparing to unveil it in the near future, according to CNBC.
What the Market Thinks About Apple Stock
Apple shares fell 0.3% during trading on August 17. They have risen 12.5% since the beginning of the year, although they have lost 6% of their value over the past month.
Most analysts covering Apple stock have a positive outlook on it: 31 out of 47 experts recommend buying it (Buy and Overweight ratings), according to MarketWatch. Another 11 advise holding (Hold), and five advise selling (Sell and Underweight).
This article was AI-translated and verified by a human editor



